Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting

被引:20
|
作者
Lacy, CR
Suh, DC
Barone, JA
Bueno, M
Moylan, D
Swartz, C
Kudipudi, RV
Kostis, JB
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Cardiovasc Dis & Hypertens, New Brunswick, NJ 08903 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Dis Management & Clin Outcomes, New Brunswick, NJ 08903 USA
[3] Rutgers State Univ, New Jersey Coll Pharm, Piscataway, NJ USA
关键词
D O I
10.1001/archinte.162.4.468
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although lipid-lowering therapy according to the National Cholesterol Education Program guidelines decreases mortality and morbidity in patients with coronary artery disease (CAD), significant undertreatment of hyperlipidemia continues to occur. This study was designed to determine the impact of an intervention targeted at improving the use of lipid-lowering therapy in patients with CAD in the hospital setting. Methods: Cardiac case managers prompted physicians to obtain lipid profiles for patients with CAD who were not receiving lipid-lowering therapy on admission and initiate lipid-lowering therapy for patients with a low-density lipoprotein level of 130 mg/dL (3.37 mmol/L) or higher during hospitalization. The study population comprised 813 patients with CAD admitted for percutaneous transluminal coronary angioplasty, coronary artery by-pass grafting, or myocardial infarction. A retrospective chart review of lipid testing and treatment rates was conducted in 300 patients in the preintervention period, and a prospective review of rates was conducted in 513 patients during the intervention period. Results: The percentage of patients with CAD not receiving lipid-lowering therapy on admission who had fractionated lipid profiles obtained during hospitalization increased from 27% preintervention to 89% during intervention (odds ratio, 18.27; 95% confidence interval, 11.61-28.74 P<.001). The percentage of patients with a low-density lipoprotein level of 130 mg/dL or higher for whom lipid-lowering therapy was initiated during hospitalization increased from 17% preintervention to 82% during intervention (odds ratio, 24.50; 95% confidence interval, 7.33-81.83 P<.001). Conclusions: The intervention provided by specialized cardiac case managers significantly increased physicians' adherence to the National Cholesterol Education Program treatment guidelines. The results of the present study suggest that intervention programs of this nature could produce a significant positive impact on cardiovascular outcomes if implemented nationally.
引用
收藏
页码:468 / 473
页数:6
相关论文
共 50 条
  • [1] Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting
    Lacy, CR
    Swartz, CD
    Moylan, DM
    Bueno, M
    Suh, DC
    Barone, JA
    Kostis, JB
    CIRCULATION, 1998, 98 (17) : 45 - 46
  • [2] Lipid-lowering therapy for patients with or at risk of coronary artery disease
    Kjekshus, J
    Pedersen, TR
    Tobert, JA
    CURRENT OPINION IN CARDIOLOGY, 1996, 11 (04) : 418 - 427
  • [3] Underutilization of lipid-lowering therapy in coronary artery disease
    Batalla, A
    Hevia, S
    Reguero, JR
    Cubero, GI
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) : 2683 - +
  • [4] Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease
    Harnick, DJ
    Cohen, JL
    Schechter, CB
    Fuster, V
    Smith, DA
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (12): : 1416 - 1420
  • [5] Lipid-lowering therapy in patients with coronary artery disease: Sex or age bias?
    Sgadari, A
    Incalzi, RA
    Onder, G
    Pedone, C
    Gambassi, G
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) : 2684 - +
  • [6] Effectiveness of hospital lipid-lowering protocol of intensive lipid-lowering therapy for patients with acute coronary syndrome
    Nakao, Sho
    Ishihara, Takayuki
    Tsujimura, Takuya
    Iida, Osamu
    Hata, Yosuke
    Toyoshima, Taku
    Higashino, Naoko
    Mano, Toshiaki
    JOURNAL OF CARDIOLOGY, 2022, 79 (03) : 391 - 399
  • [7] Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid-lowering therapy
    Yamamoto, Hiroyuki
    Shinke, Toshiro
    Otake, Hiromasa
    Kawamori, Hiroyuki
    Toba, Takayoshi
    Kuroda, Masaru
    Hirota, Yushi
    Sakaguchi, Kazuhiko
    Ogawa, Wataru
    Hirata, Ken-ichi
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (06) : 1015 - 1024
  • [8] Lipid-lowering therapy at hospital discharge after coronary artery bypass grafting
    Khanderia, U
    Faulkner, TV
    Townsend, KA
    Streetman, DS
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (06) : 548 - 551
  • [9] Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention
    Lee, Seung-Jun
    Joo, Jae Hong
    Park, Sohee
    Kim, Choongki
    Choi, Dong-Woo
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Jang, Yangsoo
    Nam, Chung-Mo
    Hong, Myeong-Ki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (05) : 401 - 410
  • [10] Intensive lipid-lowering therapy in patients with coronary heart disease
    Lauderdale, SA
    Sheehan, AH
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (02) : 329 - 334